U.S., Nov. 18 -- ClinicalTrials.gov registry received information related to the study (NCT04134429) titled 'Feasibility of Monitoring Health Data in Pediatric Patients Undergoing Chemotherapy' on Sept. 12.
Brief Summary: In this pilot study the feasibility of continous monitoring of health data with a small, on-skin wearable device (the Everion(R), by Biovotion, Zurich) in pediatric patients under chemotherapy for cancer, is studied. Feasibility is assessed by the number of patients wearing the device on seven consecutive days for at least 18h/day, what will be measured by monitored heart rate. Study duration for each participant is 14 days.
Study Type: Interventional
Condition: * Pediatric Cancer
* Febrile Neutropenia
* Chemotherapy-...